Literature DB >> 30816939

Errors in eTable 6 in the Supplement.

.   

Abstract

Year:  2019        PMID： 30816939      PMCID： PMC6459101          DOI： 10.1001/jamaophthalmol.2019.0032

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  2 in total

1.  Incorrect Data in Supplement.

Authors:  Adam R Glassman
Journal:  JAMA Ophthalmol       Date:  2019-04-01       Impact factor: 7.389

2.  Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.

Authors:  Jeffrey G Gross; Adam R Glassman; Danni Liu; Jennifer K Sun; Andrew N Antoszyk; Carl W Baker; Neil M Bressler; Michael J Elman; Frederick L Ferris; Thomas W Gardner; Lee M Jampol; Daniel F Martin; Michele Melia; Cynthia R Stockdale; Roy W Beck
Journal:  JAMA Ophthalmol       Date:  2018-10-01       Impact factor: 7.389
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.